C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
11/2004
11/24/2004	CN1548413A Beta-diketoacid as dimer compound and its prepn and use
11/24/2004	CN1176918C Intermediate of alpha-substituted benzene acetic acid derivate with farm pesticide activity
11/24/2004	CN1176904C Molecular distilling process for enriching and purifying capsaicin
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	CA2171329C Androstenones
11/23/2004	CA2118379C Preparation of acetoacetarylamides
11/18/2004	US20040230078 Economical reduced temperature and pressure reaction using such as aluminum or titanium n,n-dimethyl amine catalyst
11/18/2004	US20040229949 New 3-aryl propionic acid derivatives and analogs
11/18/2004	US20040229946 Antidiabetic agents
11/17/2004	EP1347960B1 Process for preparing (+) trans-4-p-fluorophenyl-3-hydroxymethyl-1
11/17/2004	EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004	CN1547570A Substituted c-cyclohexylmethylamine derivatives
11/16/2004	US6818638 Melvinolin derivatives
11/16/2004	US6818634 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
11/16/2004	US6818232 Oat extracts: refining, compositions and methods of use
11/16/2004	CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/11/2004	WO2004096771A1 Biaryl compounds having activity at the 5ht5a receptor
11/11/2004	WO2004075864A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
11/11/2004	WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040224992 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224900 Protease inhibitors/immunomodulator drugs; internal ribosome entry site (IRES)
11/11/2004	DE10318981A1 New metal-interacting amphiphilic compounds e.g. useful as corrosion inhibitors, adhesion promoters, primers, passivation agents or conversion layer formers
11/10/2004	EP1474381A1 Phenylalanine derivatives as herbicides
11/10/2004	EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004	EP1085009B1 Indan derivatives
11/10/2004	EP1077930B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1174960C Stabilizing agent for hydroxylamine solutions
11/09/2004	CA2170047C Androstenone derivative
11/04/2004	WO2004094413A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	WO2004094398A2 Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide
11/04/2004	WO2004093800A2 Thyronamine derivatives and analogs and methods of use thereof
11/04/2004	WO2004093799A2 Thyroid receptor ligands
11/04/2004	WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004	WO2004062612A3 Large-scale synthesis of selective androgen receptor modulators
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220079 Inhibitors of Memapsin 2 and use thereof
11/04/2004	CA2522805A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	CA2517560A1 Thyronamine derivatives and analogs and methods of use thereof
11/03/2004	EP1473288A1 Nitric ester derivatives of COX-2 inhibitors and their use for treating inflammation and cardiovascular diseases
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1317461B1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories
11/03/2004	CN1543453A 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/03/2004	CN1173934C N-acetoacetarylamides
11/02/2004	US6812368 Diastereoselective hydrogenation of 1,3-hydroxyketones
11/02/2004	US6812362 Amidation; efficiency, higher yields, performed at or near room temperature, energy savings
11/02/2004	US6811833 Birefringement film
10/2004
10/28/2004	WO2004091724A1 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
10/28/2004	WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004	US20040215020 Process for preparing (+)trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
10/28/2004	US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same
10/27/2004	EP1471052A1 Geranyl compounds
10/27/2004	EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004	EP1469827A2 Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate
10/27/2004	EP1078261B1 Method for immobilising and self-organizing biological macromolecules on carbon nanotubes and uses
10/26/2004	US6809220 Fluorescent labels for solution and solid support applications
10/21/2004	WO2004089885A1 Novel compounds
10/21/2004	WO2004089881A1 New sulfonyl derivatives of aminonaphtols
10/21/2004	WO2004089877A1 New hydroxynaphthyl amides
10/21/2004	WO2004089874A1 Biphenyl carboxylic amide p38 kinase inhibitors
10/21/2004	WO2004089539A1 A silver-catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition for the epoxidation of ethylene
10/21/2004	US20040210079 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
10/21/2004	US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004	US20040209957 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke
10/21/2004	US20040209949 Resorcinol derivatives
10/21/2004	US20040209946 Synthesis of 2-hydroxy-N,N-dimethyl-3-[[2-[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-l]aminobenzamide
10/21/2004	US20040209305 Epoxide polymer surfaces
10/21/2004	CA2521228A1 Biphenyl carboxylic amide p38 kinase inhibitors
10/21/2004	CA2520786A1 A silver-catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition for the epoxidation of ethylene
10/20/2004	EP1468680A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
10/20/2004	EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
10/20/2004	EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
10/20/2004	EP1443045A9 Carbanilide used as pesticide
10/20/2004	EP1289936B1 Substituted stilbenes as glucose uptake enhancers
10/20/2004	EP0862555B1 Substituted aryl or heteroarylamides having retinoid-like biological activity
10/20/2004	CN1538952A Protected 3,5-dihydroxy-2, 2-dimethyl-valeroamides for synthesis of epothilone and derivatives and method for production and use thereof
10/20/2004	CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
10/20/2004	CN1171857C Process for enriching and purifying capsaicin with macroporous adsorption resin
10/19/2004	US6806365 N-alkanoylphenylalamine derivatives
10/19/2004	US6805920 Polymerizable liquid crystal compound and optical film
10/14/2004	US20040204494 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions
10/13/2004	EP1466891A1 Carboxylic acid derivative
10/13/2004	EP1466889A1 Derivatives of venlafaxine and methods of preparing and using the same
10/13/2004	EP1465858A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
10/12/2004	US6803384 Diaminopropionic acid derivatives
10/12/2004	US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc
10/12/2004	CA2100817C Heteroacetic acid derivatives
10/07/2004	US20040198992 Catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition
10/07/2004	US20040198641 Hydrophobic core coupled to plurality of hydrophilic moieties that form micelles in solution; encapsulate lipoproteins; atherosclerosis; cardiovascular disorders
10/06/2004	EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof
10/06/2004	EP1463715A1 Novel glucagon antagonists
10/06/2004	EP1101755B1 Anthranilic acid derivatives
10/06/2004	CN1169805C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products

1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 157